Recent Advances in Bioequivalence Testing: Emerging Technologies and AI Tools
Explore how AI, advanced imaging, and new FDA guidelines are transforming bioequivalence testing in 2026, reducing costs and accelerating generic drug approvals.
Explore how AI, advanced imaging, and new FDA guidelines are transforming bioequivalence testing in 2026, reducing costs and accelerating generic drug approvals.